The Norwegian and German hip fracture teams have achieved an amazing milestone, in many ways even a world record. Both teams have now recruited more than 200 hip fracture participants for the ongoing Mobilise-D Clinical Validation Study. Together with the French team, we have now recruited 456 hip fracture patients for our study, an achievement that no…
The Mobilise-D consortium and the Critical Path Institute (C-Path) are thrilled to announce the signing of a collaboration agreement, which will be an important step forward in achieving lasting impact. C-Path is an independent nonprofit, public-private partnership with the U.S. Food and Drug Administration (FDA). C-Path orchestrates the development of actionable solutions through an innovative, collaborative…
We are very proud to announce that the Pulmonary Research Institute (PRI) in Grosshandorf, Schleswig-Holstein, Germany, is the first clinical site in our ongoing Clinical Validation Study that has reached their target number of included participants. They just reported that participant #140 has entered the Mobilise-D study, thereby completing their target for the COPD (Chronic…
We are proud to announce that Mobilise-D will launch a webinar series, starting in February 2022! And we kick off with a bang, featuring a discussion about THE ALGORITHMS and Digital Mobility Outcomes (DMOs). Save the dates already now for all the webinars! We have designed the first series of five webinars, twice a month (February…
We are pleased to announce that Mobilise-D is now using the Voice Global platform as part of our Patient and Public Involvement and Engagement (PPIE) activities. Voice Global is an international network of citizens who come together to provide insights, ideas and experiences to researchers to help drive innovation for ageing and improve health research. Voice is a community of patients,…
Mobilise-D and IDEA-FAST are pleased to announce the creation of the Digital Health Catalyst (DHC). Mobilise-D is working on digital mobility assessment in chronic obstructive pulmonary disease (COPD), Parkinson’s disease (PD), multiple sclerosis (MS) and recovery from proximal femoral fracture (PFF). IDEA-FAST is working to identify digital endpoints to assess fatigue, sleep disturbances and activities…